Physicochemical Stability and Pharmaceutical Compatibility of Ciprofol with Five Adjuvant Drugs for Gastrointestinal Endoscopy: An In Vitro Evaluation

Background/Objectives: Ciprofol is a novel GABAₐ-receptor agonist sedative widely used for gastrointestinal endoscopic sedation–anesthesia due to its rapid onset, fast recovery and favorable cardiovascular tolerance. Intravenous anesthetic drug administration via Y-site co-infusion is a common clinical practice during endoscopic procedures, yet systematic physicochemical compatibility data for ciprofol with adjuvant injectable agents remain limited.